
Borealis Ventures
Description
Borealis Ventures is an early-stage venture capital firm strategically located in Hanover, New Hampshire, with a strong historical and ongoing affiliation with Dartmouth College and the broader Upper Valley innovation ecosystem. Established to foster groundbreaking companies, the firm primarily focuses its investments on the dynamic sectors of Information Technology and Life Sciences. Borealis Ventures is known for partnering closely with visionary entrepreneurs who are building market-defining companies from the ground up, often leveraging deep technological or scientific advancements.
The firm's investment strategy centers on providing crucial early-stage capital, typically leading or co-leading Seed and Series A financing rounds. Their approach extends beyond mere capital injection, emphasizing active collaboration and support to help portfolio companies navigate the challenges of early growth, product development, and market penetration. Borealis Ventures seeks out opportunities where their expertise and network can significantly accelerate a company's trajectory, particularly those with a clear path to disrupting established industries or creating entirely new markets.
Borealis Ventures has demonstrated a consistent ability to raise substantial capital, reflecting investor confidence in their strategy and team. For instance, their most recent fund, Borealis Ventures V, L.P., successfully closed at $100 million in 2021, contributing to their total capital under management exceeding $250 million across all funds. The firm has built a diverse portfolio, having made over 70 investments in promising startups across its target sectors. Their typical initial investment, or first cheque, ranges from $500,000 to $5,000,000, tailored to the specific needs and stage of the early-stage company. This flexible check size allows them to support a wide spectrum of ventures, from nascent seed-stage ideas to more developed Series A companies ready for significant scaling.
Investor Profile
Borealis Ventures has backed more than 51 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 18% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Typical check size: $500K – $5M.
Stage Focus
- Series A (33%)
- Series B (20%)
- Series C (14%)
- Series Unknown (12%)
- Seed (10%)
- Series D (8%)
- Debt Financing (2%)
- Series E (2%)
Country Focus
- United States (94%)
- United Kingdom (6%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Enterprise Software
- Construction
- Therapeutics
- Life Science
- Manufacturing
- E-commerce Platforms
- Logistics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.